Ogsiveo And Winrevair Among Latest Orphan Drugs To Secure Early Access Funding In France

 
• By Francesca Bruce

HAS, the French health technology assessment body, has issued positive recommendations for several orphan drugs, including for Vyloy, which was provisionally rejected for reimbursement in the UK last year.

Several orphan drugs will receive swifter reimbursement through France's early access mechanism

More from Health Technology Assessment

More from Geography